2011 news releases and statements

16/12/2011
News release – Industry gears up for next pricing scheme negotiations
08/12/2011
News release – New ABPI President elect announced
05/12/2011
News release – Reforms will help NHS patients benefit from best new medicines and boost economy
29/11/2011
Statement – ABPI Chief Executive responds to Chancellor's Autumn Statement
01/11/2011
News release – ABPI welcomes MHRA proposal to safeguard supplies of medicines to UK patients
03/11/2011
News release – The future of healthcare in Wales
27/10/2011
News release – Innovation in healthcare
05/10/2011
Statement – Response to Health Secretary's announcement on better access to medicines for rare diseases
28/09/2011
Statement – Response to news coverage on the cost of cancer treatment, 27 September 2011
06/09/2011
News release – The new face of pharma
14/08/2011
Statement – Response to Mail on Sunday article, 14 August 2011
10/08/2011
Statement – Response to NHS steering group on medicines wastage and patient adherence
04/08/2011
Statement – Response to survey by the Independent Pharmacy Federation
02/08/2011
Statement – Response to Scottish Daily Mail article, 2 August 2011
21/07/2011
Statement – Response to Pharmaceutical Journal comment by Graham Phillips et al, Wednesday 20 July 2011
18/07/2011
Statement – Reaction to Government response on value based pricing consultation
18/07/2011
Statement – Letter in response to Scottish Daily Mail article, 9 July 2011
18/07/2011
Statement – Letter in response to Observer article, 3 July 2011
11/07/2011
Statement – Letter in response to Independent on Sunday article, 3 July 2011
04/07/2011
Statement – Letter in response to Independent on Sunday article, 3 July 2011
25/05/2011
News release – Value-based pricing must be part of a package of measures if it is to increase patient access to branded medicines
24/05/2011
News release – ABPI produces guidance to help industry demonstrate value for its products
17/05/2011
News release – ABPI and BIA to co-locate in new offices
16/05/2011
News release – Embracing innovation will help deliver better patient care
11/05/2011
News release – Earlier Access Scheme
05/04/2011
News release – Stephen Whitehead appointed new Chief Executive of ABPI
23/03/2011
Statement – Response to 2011 budget and growth review announcements
14/03/2011
News release – ABPI supports broader definition of value for any future value-based pricing
26/01/2011
News release – Stark regional variation in patient access to NICE-approved drugs
24/02/2011
News release – Leading healthcare figures pledge support for new ways of working with pharmaceutical industry
17/02/2011
Statement – Response to European Parliament vote on Falsified Medicines Directive
02/02/2011
Statement – ABPI response to comments on UK pharmaceutical industry
03/02/2011
News release – Best practice guidance on medicine supply - a step in the right direction
19/01/2011
Statement – Response to Government’s Health Bill
17/01/2011
Cancer Drugs Fund - both an opportunity and a challenge

Print this page

Get in touch

Please choose the subject of your enquiry from the list below:

Enter the above code here:

Can't read? Try different words.

Submit

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.

The Association of the British Pharmaceutical Industry

7th floor, Southside, 105 Victoria Street,
London, SW1E 6QT
Telephone +44 (0) 870 890 4333
ABPI Cymru Wales
ABPI Northern Ireland
ABPI Scotland

The Prescription Medicines Code of Practice Authority (PMCPA) is responsible for administering the ABPI Code of Practice for the Pharmaceutical Industry at arm's length of the ABPI itself.

The Office of Health Economics (OHE) provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.